News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Approves Zyga Technology, Inc. to Update Joint Fusion System Indications


8/19/2011 8:07:12 AM

The US Food & Drug Administration (FDA) has approved the Zyga Technology's request to update indications for use of its SImmetry Sacroiliac Joint Fusion System. The updated indications for use states the SImmetry Sacroliliac Joint Fusion System is intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis.

Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES